Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India-Reference-Cited by-同舟云学术

Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India

Published:2020-05-19 Issue:5 Volume:15 Page:e0233230
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Roy Debabrata^ORCID,Mahapatra Tanmay,Manna Kaushik,Kar Ayan,Rana Md Saiyed,Roy Abhishek,Bose Pallab Kumar,Banerjee Barnali,Paul Srutarshi^ORCID,Chakraborty Sandipta

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference65 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins;ES Unit;Lancet,2005

2. European Association for Cardiovascular Prevention Rehabilitation. ESC/EAS guidelines for the management of dyslipidaemias the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS);Z Reiner;Eur Heart J,2011

3. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012);J Perk;European heart journal,2012

4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;C Baigent;Lancet (London, England),2010

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Group SSSS;The Lancet,1994

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Qualitative Study Exploring the Perceived Barriers Among Patients After Percutaneous Coronary Intervention;SEPTEMBER 2023;2023-09-11

2. Comparative efficacy and safety among high-intensity statins. Systematic Review and Meta-Analysis;Journal of Comparative Effectiveness Research;2023-03

3. Atorvastatin attenuates allergic inflammation by blocking prostaglandin biosynthesis in rats with allergic rhinitis;International Immunopharmacology;2023-02

4. The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case;Rational Pharmacotherapy in Cardiology;2022-11-05

5. Statin Utilization Trend in Primary and Secondary Prevention of Cardiovascular Diseases in a Teaching Hospital;Indian Journal of Clinical Cardiology;2022-10-03